Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 5:13:1033017.
doi: 10.3389/fphar.2022.1033017. eCollection 2022.

Anti-cancer effect and potential microRNAs targets of ginsenosides against breast cancer

Meiling Fan  1 , Mengyao Shan  2   3 , Xintian Lan  2   3 , Xiaoxue Fang  2   3 , Dimeng Song  2   3 , Haoming Luo  2   3 , Donglu Wu  3   4
Affiliations
Review

Anti-cancer effect and potential microRNAs targets of ginsenosides against breast cancer

Meiling Fan et al. Front Pharmacol. .

Abstract

Breast cancer (BC) is one of the most common malignant tumor, the incidence of which has increased worldwide in recent years. Ginsenosides are the main active components of Panax ginseng C. A. Mey., in vitro and in vivo studies have confirmed that ginsenosides have significant anti-cancer activity, including BC. It is reported that ginsenosides can induce BC cells apoptosis, inhibit BC cells proliferation, migration, invasion, as well as autophagy and angiogenesis, thereby suppress the procession of BC. In this review, the therapeutic effects and the molecular mechanisms of ginsenosides on BC will be summarized. And the combination strategy of ginsenosides with other drugs on BC will also be discussed. In addition, epigenetic changes, especially microRNAs (miRNAs) targeted by ginsenosides in the treatment of BC are clarified.

Keywords: MicroRNAs; breast cancer; combination therapy; ginsenosides; molecular mechanism.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Chemical structures of ginsenosides with anti-breast cancer activity. Glc, glucose. The chemical structures of the ginsenosides included in this publication were obtained from pubchem, but ginsenoside Rp1 was drawn using the chemdraw program.
FIGURE 2
FIGURE 2
Anti-breast cancer effect of various ginsenosides.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Adams R. H., Alitalo K. (2007). Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell. Biol. 8 (6), 464–478. 10.1038/nrm2183 - DOI - PubMed
    1. Ali S. A., Abdulrahman Z. F. A., Faraidun H. N. (2020). Circulatory miRNA-155, miRNA-21 target PTEN expression and activity as a factor in breast cancer development. Cell. Mol. Biol. 66 (7), 44–50. 10.14715/cmb/2020.66.7.8 - DOI - PubMed
    1. Aumeeruddy M. Z., Mahomoodally M. F. (2019). Combating breast cancer using combination therapy with 3 phytochemicals: Piperine, sulforaphane, and thymoquinone. Cancer 125 (10), 1600–1611. 10.1002/cncr.32022 - DOI - PubMed
    1. Aung H. H., Mehendale S. R., Wang C. Z., Xie J. T., McEntee E., Yuan C. S. (2007). Cisplatin's tumoricidal effect on human breast carcinoma MCF-7 cells was not attenuated by American ginseng. Cancer Chemother. Pharmacol. 59 (3), 369–374. 10.1007/s00280-006-0278-6 - DOI - PMC - PubMed
    1. Baek N. I., Kim D. S., Lee Y. H., Park J. D., Lee C. B., Kim S. I. (1996). Ginsenoside Rh4, a genuine dammarane glycoside from Korean red ginseng. Planta Med. 62 (1), 86–87. 10.1055/s-2006-957816 - DOI - PubMed

LinkOut - more resources